BHT-3021
/ Bayhill Therap
- LARVOL DELTA
Home
Next
Prev
1 to 12
Of
12
Go to page
1
December 08, 2020
Diabetes AutoimmunitY Withdrawn in Established Patients (DAY)
(clinicaltrials.gov)
- P2b; N=0; Withdrawn; Sponsor: Tolerion, Inc.; N=216 ➔ 0; Not yet recruiting ➔ Withdrawn
Clinical • Enrollment change • Trial withdrawal • Diabetes • Immunology • Metabolic Disorders • Type 1 Diabetes Mellitus
December 08, 2020
Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN)
(clinicaltrials.gov)
- P2b; N=0; Withdrawn; Sponsor: Tolerion, Inc.; N=210 ➔ 0; Not yet recruiting ➔ Withdrawn
Clinical • Enrollment change • Trial withdrawal • Diabetes • Immunology • Metabolic Disorders • Type 1 Diabetes Mellitus
November 09, 2020
SUNRISE: Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients
(clinicaltrials.gov)
- P2; N=78; Active, not recruiting; Sponsor: Tolerion, Inc.; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed • Diabetes • Immunology • Metabolic Disorders • Type 1 Diabetes Mellitus
October 19, 2020
SUNRISE: Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients
(clinicaltrials.gov)
- P2; N=99; Recruiting; Sponsor: Tolerion, Inc.; Trial primary completion date: Aug 2021 ➔ Mar 2021
Clinical • Trial primary completion date • Diabetes • Immunology • Metabolic Disorders • Type 1 Diabetes Mellitus
September 12, 2019
Diabetes AutoimmunitY Withdrawn in Established Patients (DAY)
(clinicaltrials.gov)
- P2b; N=216; Not yet recruiting; Sponsor: Tolerion, Inc.; Trial completion date: May 2023 ➔ Dec 2023; Initiation date: May 2019 ➔ Dec 2019
Trial completion date • Trial initiation date
September 12, 2019
Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN)
(clinicaltrials.gov)
- P2b; N=210; Not yet recruiting; Sponsor: Tolerion, Inc.; Trial completion date: May 2023 ➔ Dec 2023; Initiation date: May 2019 ➔ Dec 2019
Trial completion date • Trial initiation date
July 30, 2019
SUNRISE: Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients
(clinicaltrials.gov)
- P2; N=90; Recruiting; Sponsor: Tolerion, Inc.; Not yet recruiting ➔ Recruiting; N=51 ➔ 90; Trial completion date: May 2023 ➔ Aug 2023; Trial primary completion date: May 2021 ➔ Aug 2021
Clinical • Enrollment change • Enrollment open • Trial completion date • Trial primary completion date
March 29, 2019
SUNRISE: Diabetes Autoimmunity Withdrawn In New Onset and In Established Patients
(clinicaltrials.gov)
- P2; N=51; Not yet recruiting; Sponsor: Tolerion, Inc.
Clinical • New P2 trial
March 29, 2019
Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN)
(clinicaltrials.gov)
- P2b; N=210; Not yet recruiting; Sponsor: Tolerion, Inc.; Trial completion date: Jan 2023 ➔ May 2023; Initiation date: Jan 2019 ➔ May 2019; Trial primary completion date: Jan 2021 ➔ May 2021
Clinical • Trial completion date • Trial initiation date • Trial primary completion date
March 29, 2019
Diabetes AutoimmunitY Withdrawn in Established Patients (DAY)
(clinicaltrials.gov)
- P2b; N=216; Not yet recruiting; Sponsor: Tolerion, Inc.; Trial completion date: Jan 2023 ➔ May 2023; Initiation date: Jan 2019 ➔ May 2019; Trial primary completion date: Jan 2021 ➔ May 2021
Clinical • Trial completion date • Trial initiation date • Trial primary completion date
January 07, 2019
Diabetes Autoimmunity Withdrawn in New Onset Patients (DAWN)
(clinicaltrials.gov)
- P2b; N=210; Not yet recruiting; Sponsor: Tolerion, Inc.
Clinical • New P2b trial
January 07, 2019
Diabetes AutoimmunitY Withdrawn in Established Patients (DAY)
(clinicaltrials.gov)
- P2b; N=216; Not yet recruiting; Sponsor: Tolerion, Inc.
Clinical • New P2b trial
1 to 12
Of
12
Go to page
1